Study for AZD4360 in participants with advanced solid tumours

Trial Identifier: D8930C00001
Sponsor: AstraZeneca
Start Date: April 2025
Primary Completion Date: March 2027
Study Completion Date: December 2027
Condition: Liver Cancer; Gastric Cancer; Esophageal cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100730
CN Chengdu, CN, 610041
CN Shanghai, CN, 201318
CN Wuhan, CN, 430040
DE Berlin, DE, 12200
DE Dresden, DE, 01307
DE Frankfurt, DE, 60488
GB Glasgow, GB, G12 0YN
GB London, GB, EC1A 7BE
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 227-8577
JP Koto-ku, JP, 135-8550
US, CA Santa Monica, CA, US, 90404
US, RI Providence, RI, US, 02903
US, TX Houston, TX, US, 77030